NCT04463719

Brief Summary

There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate. The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer and conduct a pilot clinical trial to evaluate the feasibility of conducting a larger efficacy study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 9, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

February 20, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 10, 2025

Completed
Last Updated

November 10, 2025

Status Verified

December 1, 2024

Enrollment Period

2.6 years

First QC Date

July 6, 2020

Results QC Date

August 28, 2025

Last Update Submit

October 24, 2025

Conditions

Keywords

thyroid nodulesshared decision making

Outcome Measures

Primary Outcomes (1)

  • Proportion of Eligible Patients for Feasibility

    Proportion of participants that are eligible relative to total trial referrals.To measure the proportion of eligible patients after review of upcoming clinical visits, enrollment and refusal reasons, ability to randomize patients and tolerability by patients and clinicians of the required assessments (time to complete assessments and obtain complete assessment at 6 months of follow up).

    at 6 months of follow up

Secondary Outcomes (16)

  • Patient's Acceptance to Participate in the Study

    first visit

  • Adequate Randomization

    initial clinical visit

  • Completeness of Baseline Survey (Patients)

    baseline

  • Patient Survey (6 Months)

    6 months

  • Clinician Baseline Survey

    baseline

  • +11 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Counseling using the electronic conversation aid

Behavioral: Counseling using the electronic conversation aid

Control Group

ACTIVE COMPARATOR

Routine counseling only

Behavioral: counseling by routine care

Interventions

Patients receive counseling about thyroid biopsy with the use of the conversation aid.

Intervention group

Patients receive counseling by routine care without the use of the conversation aid

Control Group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults \>18 years old presenting for evaluation of a thyroid nodule

You may not qualify if:

  • Patients with hyperthyroidism
  • Patients with previous biopsy of the nodule of interest
  • Pregnant patients
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Florida

Gainesville, Florida, 32610, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Thyroid NoduleThyroid Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Results Point of Contact

Title
Naykky Singh Ospina
Organization
University of Florida

Study Officials

  • Naykky Singh Ospina

    University of Florida

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2020

First Posted

July 9, 2020

Study Start

February 20, 2022

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

November 10, 2025

Results First Posted

November 10, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations